MREO
Mereo BioPharma Group plc
$0.32
-0.02 (-5.37%)
At close · Jul 6
Market Cap
$252.68M
Shares
798,093,044
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-14 | — | |
| 8-K/A | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| DEF 14A | 2026-04-09 | 2026-04-08 | |
| 8-K | 2026-03-27 | 2026-03-26 | |
| 10-K | 2026-03-19 | 2025-12-31 | |
| 8-K | 2026-03-19 | — | |
| 8-K | 2026-02-17 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-29 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-07-10 | 2025-07-09 | |
| 8-K | 2025-05-14 | 2025-05-13 | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| DEF 14A | 2025-04-08 | 2025-05-13 | |
| 8-K | 2025-03-26 | — | |
| 10-K | 2025-03-26 | 2024-12-31 | |
| 8-K | 2025-01-13 | 2025-01-12 | |
| 8-K | 2024-11-12 | 2024-11-08 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-06-14 | — | |
| 8-K | 2024-06-12 | 2024-06-11 | |
| 8-K | 2024-05-23 | — | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-05-15 | — | |
| DEF 14A | 2024-04-24 | 2024-05-23 | |
| 8-K | 2024-04-15 | — | |
| 10-K | 2024-03-27 | 2023-12-31 | |
| 8-K | 2024-03-27 | — | |
| 8-K | 2024-01-08 | — | |
| 6-K | 2023-12-18 | — | |
| 6-K | 2023-11-29 | — | |
| 6-K | 2023-11-16 | — | |
| 6-K | 2023-10-23 | — | |
| 6-K | 2023-10-17 | — | |
| 6-K | 2023-09-20 | — | |
| 6-K | 2023-09-07 | 2023-06-30 | |
| 6-K | 2023-07-06 | — | |
| 6-K | 2023-06-30 | — | |
| 6-K | 2023-06-07 | — | |
| 6-K | 2023-06-05 | — | |
| 6-K | 2023-05-22 | — | |
| 6-K | 2023-05-08 | — |
Showing 1–50 of 135 filings